BENJ vs. CANC
BENJ (Horizon Landmark ETF) and CANC (Tema Oncology ETF) are both exchange-traded funds - BENJ is a Ultrashort Bond fund actively managed by Horizon, while CANC is a Health & Biotech Equities fund actively managed by Tema. Both are actively managed. Over the past year, BENJ returned 3.81% vs 47.37% for CANC. At a correlation of -0.12, they often move in opposite directions. BENJ charges 0.40%/yr vs 0.75%/yr for CANC.
Performance
BENJ vs. CANC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BENJ achieves a 1.47% return, which is significantly lower than CANC's 4.82% return.
BENJ
- 1D
- 0.01%
- 1M
- 0.31%
- YTD
- 1.47%
- 6M
- 1.83%
- 1Y
- 3.81%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CANC
- 1D
- 0.08%
- 1M
- -3.73%
- YTD
- 4.82%
- 6M
- 3.86%
- 1Y
- 47.37%
- 3Y*
- 107.76%
- 5Y*
- —
- 10Y*
- —
BENJ vs. CANC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
BENJ Horizon Landmark ETF | 1.47% | 3.75% |
CANC Tema Oncology ETF | 4.82% | 35.44% |
Correlation
The correlation between BENJ and CANC is -0.14, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.14 |
Correlation (All Time) Calculated using the full available price history since Jan 24, 2025 | -0.13 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BENJ vs. CANC — Risk / Return Rank
BENJ
CANC
BENJ vs. CANC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Horizon Landmark ETF (BENJ) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BENJ | CANC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.64 | ||
| Sortino ratioReturn per unit of downside risk | +6.26 | ||
| Omega ratioGain probability vs. loss probability | 5.02 | 1.34 | +3.69 |
| Calmar ratioReturn relative to maximum drawdown | 9.79 | 5.49 | +4.30 |
| Martin ratioReturn relative to average drawdown | 46.19 | 14.62 | +31.57 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BENJ | CANC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 5.70 | 2.06 | +3.64 |
Sharpe Ratio (All Time)Calculated using the full available price history | 6.43 | -0.04 | +6.47 |
Drawdowns
BENJ vs. CANC - Drawdown Comparison
The maximum BENJ drawdown since its inception was -0.39%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for BENJ and CANC.
Loading charts...
Drawdown Indicators
| BENJ | CANC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -0.39% | -97.53% | +97.14% |
Max Drawdown (1Y)Largest decline over 1 year | -0.39% | -8.67% | +8.28% |
Max Drawdown (3Y)Largest decline over 3 years | — | -30.27% | — |
Current DrawdownCurrent decline from peak | 0.00% | -56.55% | +56.55% |
Average DrawdownAverage peak-to-trough decline | -0.02% | -73.19% | +73.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.08% | 3.25% | -3.17% |
Volatility
BENJ vs. CANC - Volatility Comparison
The current volatility for Horizon Landmark ETF (BENJ) is 0.06%, while Tema Oncology ETF (CANC) has a volatility of 6.26%. This indicates that BENJ experiences smaller price fluctuations and is considered to be less risky than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BENJ | CANC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.06% | 6.26% | -6.20% |
Volatility (6M)Calculated over the trailing 6-month period | 0.23% | 16.69% | -16.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.67% | 23.11% | -22.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.60% | 280.27% | -279.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.60% | 280.27% | -279.67% |
BENJ vs. CANC - Expense Ratio Comparison
BENJ has a 0.40% expense ratio, which is lower than CANC's 0.75% expense ratio.
Dividends
BENJ vs. CANC - Dividend Comparison
BENJ has not paid dividends to shareholders, while CANC's dividend yield for the trailing twelve months is around 0.05%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
BENJ Horizon Landmark ETF | 0.00% | 0.00% | 0.00% | 0.00% |
CANC Tema Oncology ETF | 0.05% | 0.06% | 3.00% | 0.56% |
Frequently Asked Questions
BENJ and CANC have a correlation of -0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CANC has higher volatility (6.26%) compared to BENJ (0.06%). In terms of maximum drawdown, BENJ dropped -0.39% vs CANC's -97.53%.
On 1-year performance, CANC leads with 47.37% vs 3.81% for BENJ. On fees, BENJ is cheaper at 0.40% per year. On volatility, BENJ has been the lower-risk option at 0.06%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, CANC has performed better with a 47.37% return vs 3.81%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BENJ is cheaper with a 0.40% expense ratio, compared with 0.75% for CANC.
CANC has the higher dividend yield at 0.05%, compared with 0.00% for BENJ.
BENJ is categorized as Ultrashort Bond, while CANC is Health & Biotech Equities. They also come from different issuers: Horizon and Tema. Their fees differ too: 0.40% for BENJ and 0.75% for CANC.
BENJ currently has the higher Sharpe Ratio (5.70 vs 2.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BENJ and CANC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer